tetramethylpyrazine has been researched along with Alcoholic Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X; Ge, T; Jiang, Y; Jin, H; Lu, C; Shao, Y; Shi, W; Wang, X; Wu, R; Xu, W; Yue, C; Zhou, Y | 1 |
| Chen, L; Chen, Q; Jin, H; Lu, C; Lu, Y; Shao, J; Wu, L; Xu, W; Zhang, F; Zheng, S | 1 |
2 other study(ies) available for tetramethylpyrazine and Alcoholic Liver Diseases
| Article | Year |
|---|---|
Activation of UQCRC2-dependent mitophagy by tetramethylpyrazine inhibits MLKL-mediated hepatocyte necroptosis in alcoholic liver disease.
Topics: Electron Transport Complex III; Hepatocytes; Humans; Liver Diseases, Alcoholic; Mitophagy; Necroptosis; Protein Kinases; Pyrazines | 2022 |
Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Fatty Liver; Liver Diseases, Alcoholic; Male; Oxidative Stress; Pyrazines; Rats; Rats, Sprague-Dawley | 2015 |